Leave the editing and optimization to us so you can focus your research.

Advancing your immunological research just got seamless.

Whether you're working with CD4+ or CD8+ T cells, our next-generation Knockout T cell Pools are paving the way for safer, more effective, and agile healthcare studies.

Video: Edited T Cells are seen killing a target cell via a BiTE antibody-mediated “redirected tumor killing” assay. Bright Field: CD8+ T Cells. Green: CFSE labeled Raji (CD19+) Cells. Red: Dead cells stained with DRAQ7 membrane impermeable viability dye. 

On-Demand Webinar: Efficient T cell engineering through the EditCo CRISPR Platform

Fast-track your findings without compromising functionality.

Using gene editing to advance your research should be an intuitive part of your workflow—not a difficult process that requires months of planning and endless resources. Consider our tools your bridge between theory and therapeutic breakthroughs. Avoid sinking time and resources into optimization and spend more time realizing impactful research outcomes. 

With this new tool fueling your lab’s research, you can leverage: 

• Guaranteed editing efficiency: Our unique multi-guide technology provides optimized guide design, so you can expect more than 80 percent editing efficiency. 
• Functional cells for reliable assays: With proven post-editing performance, our T-cells provide the confidence you need to drive your discoveries forward. 
• Save precious time and resources: Don’t risk slowdowns or valuable samples when you can get two vials of more than 1 million cells in less than three weeks.

Download the Poster:

High Quality On-Demand Gene Edited Human Primary T cells

Read our blog:

Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells

With proven post-editing performance, viability, and functionality, our T-cells are ready to give you the confidence you need to drive your discoveries forward. Read more and view data with our CD4+ T cell and CD8+ T cell flyers.